Procalcitonina es superior a recuento linfocitario, índice neutrófilo/linfocito y proteína C reactiva para la predicción de mortalidad a 30 días de pacientes con COVID-19 en el servicio de urgencias

López-Ayala, Pedro; Alcaraz-Serna, Ana; Valls Carbó, Adrián; Cuadrado Cenzual, Ma Ángeles; Torrejón Martínez, María José; López Picado, Amanda; Martínez Valero, Carmen; Miranda, Juan de D; Díaz del Arco, Cristina; Cozar López, Gabriel.
Emergencias (Sant Vicenç dels Horts) ; 34(2): 119-127, abr. 2022. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-203357

Documentos relacionados

  1. Procalcitonin concentration in the emergency department predicts 30-day mortality in COVID-19 better than the lymphocyte count, the neutrophil-tolymphocyte ratio, or the C-reactive protein level.
  2. Clinical relevance of procalcitonin values in bacteremia.
  3. Bacteremia detection from complete blood count and differential leukocyte count with machine learning: complementary and competitive with C-reactive protein and procalcitonin tests.
  4. Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers.
  5. Discriminative performance of pancreatic stone protein in predicting ICU mortality and infection severity in adult patients with infection: a systematic review and individual patient level meta-analysis.
  6. Comparison of Procalcitonin With Commonly Used Biomarkers and Algorithms for Evaluating Suspected Pediatric Musculoskeletal Infection in the Emergency Department.
  7. [Serum procalcitonin in patients with pulmonary infection and central nervous system injury].
  8. C-Reactive Protein, Procalcitonin, and White Blood Count to Rule Out Neonatal Early-onset Sepsis Within 36 Hours: A Secondary Analysis of the Neonatal Procalcitonin Intervention Study.
  9. Discriminative Accuracy of Procalcitonin and Traditional Biomarkers in Pediatric Acute Musculoskeletal Infection.
  10. A Study of Procalcitonin as an Early Predictor of Severity in Acute Pancreatitis.